<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html dir="ltr" xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml">
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>

<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<!-- 
	This website is powered by TYPO3 - inspiring people to share!
	TYPO3 is a free open source Content Management Framework initially created by Kasper Skaarhoj and licensed under GNU/GPL.
	TYPO3 is copyright 1998-2015 of Kasper Skaarhoj. Extensions are copyright of their respective owners.
	Information and contribution at http://typo3.org/
-->



<title>INHN: Barry Blackwell’s reply to Samuel Gershon’s comment</title>
<meta name="generator" content="TYPO3 4.5 CMS" />

<link rel="stylesheet" type="text/css" href="IMAGES/STYLESHEET_9B1E31873F2366.CSS?1645000983" media="all" />



<script src="IMAGES/JAVASCRIPT_93077BB238F3E1.JS?1645000982" type="text/javascript"></script>


<link href="IMAGES/LAYOUT_3COL_STANDARD.CSS" rel="stylesheet" type="text/css" /><!--[if lte IE 7]><link href="fileadmin/styles/patches/../01_layouts_basics/css/patches/patch_3col_standard.css" rel="stylesheet" type="text/css" /><![endif]-->
<meta name="DC.title" content="Barry Blackwell’s reply to Samuel Gershon’s comment" />
<meta name="description" content="INHN" />
<meta name="DC.Description" content="INHN" />
<meta name="keywords" content="International Network for the History of Neuropsychopharmacology" />
<meta name="DC.Subject" content="International Network for the History of Neuropsychopharmacology" />
<meta name="copyright" content="Copyright INHN 2012-14" />
<meta name="DC.Rights" content="Copyright INHN 2012-14" />
<meta http-equiv="content-language" content="en" />
<meta name="DC.Language" scheme="NISOZ39.50" content="en" />
<link rev="made" href="mailto:inhn@inhn.org" />
<meta http-equiv="reply-to" content="inhn@inhn.org" />
<meta name="author" content="Gregers Wegener" />
<meta name="DC.Creator" content="Gregers Wegener" />
<meta name="rating" content="General" />
<meta name="date" content="2016-03-30T12:39:51+00:00" />
<meta name="DC.date" content="2016-03-30T12:39:51+00:00" />
<meta name="robots" content="index,follow" />
<meta name="revisit-after" content="7" />
<link rel="start" href="INDEX681A.HTM?id=1" />
<link rel="up" href="INDEXFB00.HTM?id=829" />
<link rel="next" href="INDEXBE82.HTM?id=1302" />
<link rel="prev" href="INDEXF1E5.HTM?id=1216" />
<link rel="canonical" href="INDEX450C.HTM?id=1292" />



</head>
<body id="pageUID-1292">


<div id="page_margins">
	<div id="page">
		<div id="header"><div class="tx-macinasearchbox-pi1">
		
<form action="https://inhn.org/index.php?id=5&amp;L=0" method="post" name="searchform" id="searchform">
<input name="tx_indexedsearch[sword]" type="text" value="Enter search word..." onclick="this.value=''" onblur="this.value='Enter search word...'" /><br />
<input type="hidden" name="tx_indexedsearch[_sections]" value="0" />
<input type="hidden" name="tx_indexedsearch[pointer]" value="0" />
<input type="hidden" name="tx_indexedsearch[ext]" value="0" />
<input type="hidden" name="tx_indexedsearch[lang]" value="0" />
</form>

	</div>
	<div id="topnav"><a class="skip" href="#navigation" title="Direkt zur Navigation springen">Zur Navigation springen</a><span class="hideme">.</span><a class="skip" href="#content" title="Direkt zum Content springen">Zum Content springen</a><span class="hideme">.</span><a href="INDEX3A9F.HTM?id=6" target="_self">Sitemap</a>&nbsp;&#124;&nbsp;<a href="INDEXD61C.HTM?id=5" target="_self">Search</a>&nbsp;&#124;&nbsp;<a href="INDEX65E4.HTM?id=kontakt" target="_self">Contact</a>&nbsp;&#124;&nbsp;<a href="INDEXB7B8.HTM?id=204" target="_self">About INHN</a></div><a href="INDEX2999.HTM?id=202"><img class="headImg1" src="IMAGES/COMPANY_LOGO.GIF" alt="" title="Home" width="598" height="100" /></a></div>
		<div id="nav"><a id="navigation" name="navigation"></a><div id="nav_main" class="hlist"><ul><li><a href="INDEX2999.HTM?id=202" target="_self"><span>Home</span></a></li><li><a href="INDEX7EFD.HTM?id=479" target="_self"><span>Dictionary</span></a></li><li><a href="INDEX3E5C.HTM?id=374" target="_self"><span>Drugs</span></a></li><li><a href="INDEXDBB1.HTM?id=565" target="_self"><span>Photos</span></a></li><li><a href="INDEXD919.HTM?id=342" target="_self"><span>Profiles</span></a></li><li id="current"><a href="INDEXAF9F.HTM?id=355" target="_self"><span>Controversies</span></a></li><li><a href="INDEXD122.HTM?id=641" target="_self"><span>Discoveries</span></a></li><li><a href="INDEX1F24.HTM?id=384" target="_self"><span>Books</span></a></li><li><a href="INDEX3958.HTM?id=467" target="_self"><span>Biographies</span></a></li><li><a href="INDEX677F.HTM?id=642" target="_self"><span>Perspectives</span></a></li><li><a href="INDEX8C00.HTM?id=343" target="_self"><span>Archives</span></a></li><li><a href="INDEX06CB.HTM?id=368" target="_self"><span>Ebooks</span></a></li><li><a href="INDEXA1F1.HTM?id=1755" target="_self"><span>Collated</span></a></li><li><a href="INDEXDF25.HTM?id=4128" target="_self"><span>Multilingual Project</span></a></li><li><a href="INDEXABE4.HTM?id=3884" target="_self"><span>INHN Publisher</span></a></li></ul></div></div>
		<div id="main">
			<div id="teaser" class="clearfix"><div class="rootline">You are here: <a href="INDEXAF9F.HTM?id=355" target="_self">Controversies</a>&nbsp;/&nbsp;<a href="INDEXFB00.HTM?id=829" target="_self">Barry Blackwell: Adumbration; A history lesson</a>&nbsp;/&nbsp;Barry Blackwell’s reply to Samuel Gershon’s comment</div><div class="langMenu"><div class="tx-srlanguagemenu-pi1">
		
	</div>
	</div></div>
			<div id="col1">
				<div id="col1_content" class="clearfix">
					<ul id="submenu"><li id="title">Controversies</li><li><a href="INDEX01FF.HTM?id=3395" target="_self">Jay D. Amsterdam and Leemon B. McHenry: The Paroxetine 352 Bipolar Study Revisited: Deconstruction of Corporate and Academic Misconduct.</a><span class="hidden">.</span></li><li><a href="INDEXC230.HTM?id=486" target="_self">Thomas A. Ban: Conflict of interest in neuropsychopharmacology</a><span class="hidden">.</span></li><li><a href="INDEX2AF5.HTM?id=1342" target="_self">Thomas A. Ban: Development of our Vocabulary</a></li><li><a href="INDEX1BE7.HTM?id=3220" target="_self">Thomas A. Ban:  Education in Biological Psychiatry – Homage to Dr. Heinz E. Lehmann</a></li><li><a href="INDEXFB00.HTM?id=829" target="_self">Barry Blackwell: Adumbration; A history lesson</a><span class="hidden">.</span><ul><li><a href="INDEX9CA6.HTM?id=1028" target="_self">Comment by Edward Shorter</a></li><li><a href="INDEX2B84.HTM?id=1127" target="_self">Barry Blackwell’s reply to Edwrd Shorter’s comment</a></li><li><a href="INDEXFCAA.HTM?id=1177" target="_self">Andre Barciela Vera's comment</a></li><li><a href="INDEX0BF9.HTM?id=1208" target="_self">Barry Blackwells reply to Andre Barciela Vera’s comment</a></li><li><a href="INDEXF1E5.HTM?id=1216" target="_self">Samuel Gershon’s comment</a></li><li><strong>Barry Blackwell’s reply to Samuel Gershon’s comment</strong></li><li><a href="INDEXBE82.HTM?id=1302" target="_self">Donald F. Klein's comment on Barry Blackwell’s reply to Andre Vera’s comment</a></li><li><a href="INDEX6B65.HTM?id=1313" target="_self">Samuel Gershon’s response to BarryBlackwell’s reply</a></li><li><a href="INDEX6DCC.HTM?id=1323" target="_self">Barry Blackwell’s reply to Donald F. Klein's response to Donald F. Klein's comment on his reply to Andre Veras' comment</a></li></ul></li><li><a href="INDEX7196.HTM?id=3970" target="_self">Barry Blackwell: A Tale of Two Pioneers.</a></li><li><a href="INDEXD39F.HTM?id=1665" target="_self">Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry</a><span class="hidden">.</span></li><li><a href="INDEXF833.HTM?id=1944" target="_self">Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry. Revised</a><span class="hidden">.</span></li><li><a href="INDEX8B56.HTM?id=778" target="_self">Barry Blackwell: The anxiety enigma</a><span class="hidden">.</span></li><li><a href="INDEX8B7A.HTM?id=2096" target="_self">Barry Blackwell: The Baby and The Bath Water</a><span class="hidden">.</span></li><li><a href="INDEX07C2.HTM?id=622" target="_self">Barry Blackwell: The lithium controversy: A historical autopsy</a><span class="hidden">.</span></li><li><a href="INDEX12D3.HTM?id=1369" target="_self">Pierre Baumann and Francois Ferrero: An official inqury of the clinical research activities (1946-1972) of Roland Kuhn (1912-2005)</a><span class="hidden">.</span></li><li><a href="INDEXA7C8.HTM?id=2954" target="_self">John Court: A note on the history of Anorexia Nervosa</a></li><li><a href="INDEX32F0.HTM?id=421" target="_self">Paul Devenyi: Addictions are not treatable diseases</a><span class="hidden">.</span></li><li><a href="INDEXE29D.HTM?id=477" target="_self">Paul Devenyi: Pharmacotherapy of addictions</a></li><li><a href="INDEXC591.HTM?id=3315" target="_self">Camille Drach Hojaij: Stein and Empathic Fulfilment.</a><span class="hidden">.</span></li><li><a href="INDEX3CB5.HTM?id=2526" target="_self">François Ferrero: Inquiry of the Geneva 1980s’ Psychiatry Crisis</a><span class="hidden">.</span></li><li><a href="INDEXC947.HTM?id=3727" target="_self">Max Fink: Reconceptualization of Catatonia.</a><span class="hidden">.</span></li><li><a href="INDEX3D6D.HTM?id=2322" target="_self">Ernst J. Franzek: From the dichotomy to a three-part grouping of endogenous psychoses</a><span class="hidden">.</span></li><li><a href="INDEX031F.HTM?id=3472" target="_self">Samuel Gershon: Brintellix  -  votioxetine</a></li><li><a href="INDEXCD60.HTM?id=3191" target="_self">Samuel Gershon: Device for naltrexone delivery</a></li><li><a href="INDEX8E42.HTM?id=3064" target="_self">Samuel Gershon: Ketamine, the “new” breakthrough in the treatment of depression</a><span class="hidden">.</span></li><li><a href="INDEX1823.HTM?id=2488" target="_self">Samuel Gershon: Lithium history</a><span class="hidden">.</span></li><li><a href="INDEX5D83.HTM?id=3646" target="_self">Samuel Gershon: The emergence of “new” drugs in recent years.</a></li><li><a href="INDEXFA6F.HTM?id=3375" target="_self">Samuel Gershon: The Tacrine paradigm.</a><span class="hidden">.</span></li><li><a href="INDEXF3E3.HTM?id=670" target="_self">Samuel Gershon: The trazodone cntrovery and its potential fatal consequences</a></li><li><a href="INDEX4A93.HTM?id=2894" target="_self">Ken Gillman: Medical science publishing: A slow-motion train wreck</a><span class="hidden">.</span></li><li><a href="INDEXDBE8.HTM?id=3720" target="_self">David Healy: Do Randomized Controlled Trials Add to or Subtract from Clinical Knowledge?</a><span class="hidden">.</span></li><li><a href="INDEX3202.HTM?id=1350" target="_self">David Healy: The shipwreck of the singular</a><span class="hidden">.</span></li><li><a href="INDEX2555.HTM?id=2447" target="_self">Hanfried Helmchen: The role of psychopharmacotherapy in the early development of social psychiatry in Germany</a><span class="hidden">.</span></li><li><a href="INDEXE41A.HTM?id=2095" target="_self">Carlos R. Hojaij: A Psychopathological Marker For Biological Psychiatry:  The Point of No Return and the “Something New&quot; *</a></li><li><a href="INDEX4C30.HTM?id=1823" target="_self">Carlos R. Hojaij: “DSM-5: The Future of Psychiatric Diagnosis” or Continuing the Psychiatry DiSMantlement</a><span class="hidden">.</span></li><li><a href="INDEX14F7.HTM?id=2103" target="_self">Carlos R. Hojaij: Psychiatry and Medicine</a></li><li><a href="INDEX711C.HTM?id=2118" target="_self">Carlos R. Hojaij: Towards a Psychiatric Biology</a></li><li><a href="INDEX61B8.HTM?id=3147" target="_self">David Janowsky: Cholinergic muscarinic mechanisms in depression and mania</a><span class="hidden">.</span></li><li><a href="INDEXC12C.HTM?id=3956" target="_self">Daniel Kanofsky and Mary E. Woesner: A Fresh Air Approach to COVID-19.</a><span class="hidden">.</span></li><li><a href="INDEX0B8F.HTM?id=530" target="_self">Martin M. Katz: Component-Specific vs. Diagnosis-Specific Clinical Trial in Depression</a><span class="hidden">.</span></li><li><a href="INDEXBDA3.HTM?id=594" target="_self">Martin M. Katz: Multivantaged vs. conventional assessment method</a><span class="hidden">.</span></li><li><a href="INDEX46C5.HTM?id=496" target="_self">Martin M. Katz: Onset of clinical action of antidepressants</a><span class="hidden">.</span></li><li><a href="INDEX94E9.HTM?id=1147" target="_self">Martin  M. Katz: The need and rationale for shortenng the clinical trial for antidepressants</a></li><li><a href="INDEXB724.HTM?id=2329" target="_self">Donald F. Klein, Max Fink, Edward Shorter and Thomas A. Ban: Comment exchange on Flagrant Catatonic Behavior.</a><span class="hidden">.</span></li><li><a href="INDEXA16A.HTM?id=1625" target="_self">Joseph Knoll: Controversies on selegiline/(-)-deprenyl’s  pharmacological spectrum after more than 50 years of its development</a></li><li><a href="INDEX98B4.HTM?id=2771" target="_self">Magda Malewska-Kasprzak, Agnieszka Permoda-Osip, Janusz Rybakowski:Disturbances of the purinergic system in affective disorders and schizophrenia</a><span class="hidden">.</span></li><li><a href="INDEXBB29.HTM?id=4134" target="_self">Trudo Lemmens. “Medical Assistance in Dying” (Euthanasia and Assisted Suicide) in Canada: A Case Raises Questions About Its Use in Patients with Disability and Mental Illness.</a><span class="hidden">.</span></li><li><a href="INDEXEBA9.HTM?id=3891" target="_self">Amy S. F. Lutz: The Rise and Fall of the Dexamethasone Suppression Test: Stability, Consensus, Closure.</a><span class="hidden">.</span></li><li><a href="INDEX41D4.HTM?id=3252" target="_self">Gin S. Malhi: A critical analysis of concepts in psychiatry</a><span class="hidden">.</span></li><li><a href="INDEXD25B.HTM?id=2701" target="_self">Antonio E. Nardi, Richard Balon, Guy Chouinard, Fiammetta Cosci, Steven Dubovsky, Giovanni A. Fava, Rafael C. Freire, David J. Greenblatt, John H. Krystal, Karl Rickels, Thomas Roth, Carl Salzman, Richard I. Shader, Edward K. Silberman, Nicoletta Sonino,</a><span class="hidden">.</span></li><li><a href="INDEX4CFC.HTM?id=2972" target="_self">János Radó: Renal Toxicity of Lithium in Historical Perspective with Special Reference To Nephrogenic Diabetes Insipidus and its Treatment</a><span class="hidden">.</span></li><li><a href="INDEXD26F.HTM?id=3140" target="_self">Janos Radó: Desmopressin may counteract polyuria in lithium-induced nephrogenic diabetes insipidus. Review of the literature</a><span class="hidden">.</span></li><li><a href="INDEX13F5.HTM?id=1248" target="_self">Shridhar Sharma: Insulin coma treatment: Facts and controversies</a><span class="hidden">.</span></li><li><a href="INDEX5461.HTM?id=390" target="_self">Edward Shorter: The Q-T interval and the Mellaril story - a cautionary tale</a><span class="hidden">.</span></li><li><a href="INDEX70B9.HTM?id=2755" target="_self">Leonardo Tondo: Brief History of Suicide in Western Cultures</a><span class="hidden">.</span></li><li><a href="INDEX7938.HTM?id=2000" target="_self">Hector Warnes: The gut-brain axis</a><span class="hidden">.</span></li><li><a href="INDEXEABE.HTM?id=3450" target="_self">Hector Warnes: Pyridoxine in the treatment of lithium-induced tremor.</a><span class="hidden">.</span></li></ul>
					
					<div class="textBelowMenu"><!--TYPO3SEARCH_begin--><!--TYPO3SEARCH_end--></div>
				</div>
			</div>
			<div id="col2">
				<div id="col2_content" class="clearfix"><!--TYPO3SEARCH_begin--><!--TYPO3SEARCH_end--></div>
			</div>
			<div id="col3">
			  <a id="content" name="content"></a>
				<div id="col3_content" class="clearfix">
					<div class="floatbox"><!--TYPO3SEARCH_begin--><div id="c2774" class="csc-default"><h1 class="G" style="background:url(IMAGES/01C6B13EC8.PNG) no-repeat;">Barry Blackwell’s reply to Samuel Gershon’s comment</h1><p>Barry Blackwell: Adumbration: A History Lesson - <b>Barry Blackwell’s reply to Sam Gershon’s comment</b></p>
<p>Sam’s kind comment is directed not so much to the specifics of my essay but to the underlying issue, which is “exploring or ignoring the past to explain the present.” This is a topic for which he advocates a “wider discussion” involving contemporary medical practice, medical education and scientific journalism.</p>
<p>I believe it is true that economic factors, eroding ethics and professional greed have created a radically different modern Zeitgeist compared to the early days portrayed in the ten volumes of<i> The Oral History of Neuropsychopharmacology</i> edited by Tom Ban (ACNP, 2011). Much of this is discussed in my memoir, <i>Bits and Pieces of a Psychiatrist’s Life</i> (Blackwell, 2012) and some of the impact and implications for contemporary psychopharmacologists are portrayed in the biographies of prominent pioneers in our field. (See INHN.org in <i>Biographies</i>).</p>
<p>With this larger scope available as background, I will comment briefly here on the three domains Sam mentions. With regard to medical practice Sam draws attention to the consequences that flow when formerly independent practitioners become salaried employees of large healthcare corporations, a rapidly increasing problem including all full-time hospitalists, many primary care physicians, some psychiatrists and occasional psychiatric administrators or CEO’s. Despite their alleged “not-for-profit” status (to evade taxation) these corporations are driven by a “bottom line” mentality expressed by the administrators at my former hospital uttering the glib axioms <i>“No Margin, No Mission” </i>and <i>“Every bucket must carry its own water.” </i>Resources were diverted away from faculty stipends and medical education towards administrative salaries, advertising campaigns and competitive building programs to create hegemony, aggravated by declining bed occupancies and income due to federally mandated DRG’s, managed care guidelines, insurance company parsimony (prior to alleged parity) and low Medicaid reimbursement. During the 1980’s and 1990’s, five inner city hospitals in Milwaukee merged and later went bankrupt. Some of these events are described in my JAMA editorial (Blackwell, 1994).</p>
<p>Eventually, the hospital, where I was Chair of the academic program in psychiatry, was taken over by the largest health care consortium in the region. In the Department of Family Medicine, faculty was given the choice of no longer treating inner city Medicaid patients or resigning. The Department of Psychiatry was disbanded, the inpatient unit closed and the residents dispersed, contributing to a lack of psychiatrists and beds in a city plagued by homelessness and chronic recidivism reminiscent of the early days of deinstitutionalization, aggravated by the remaining psychiatrists in private practice declining to accept Medicaid patients.</p>
<p>The academic family medicine department and its residency program were eventually closed; the Chairman accepted a job with the health care corporation and is now it’s CEO, earning an annual salary in excess of $4 million.</p>
<p>Sam notes that employed physicians are now subject to productivity quotas and hospital residency training programs now progressively restrict the time allowed for interviews. After entering practice, salary levels are adjusted according to “productivity”. This discourages physicians from accepting time consuming patients, the elderly, mentally ill, Medicaid or Medicare recipients.</p>
<p>As a medical student at our local private Medical School, my son’s tuition was $40,000 a year. A previous magna cum laude student at another university in politics, philosophy and economics, he was ineligible for health insurance under his parent’s policy. The medical school, with a large well organized practice plan, offered no heath care to students but would loan him another $10,000 to purchase it. He declined, obtained Medicaid and was offered food stamps he never asked for! The medical school auditorium has a ten foot statue of Hippocrates guarding the entrance to its library. His oath, that students are asked to endorse, states medical education should be “<i>without fee or covenant”. </i>There is no better example of the greed that is now endemic in medicine than the disappearance of <i>“professional courtesy”</i> coincident with the ability of our procedure performing colleagues to become millionaires. My son opted for family medicine and is very happy, living one block away from where he grew up and in walking distance to his office.</p>
<p>During my fifty year career as an academic with the “publish or perish” motto hanging over my head, I had cordial relationships with the editors of many journals who accepted my research or for whom I worked <i>pro bono</i> as a reviewer. After retirement, I sought to obtain a copy of the editorial I had written for JAMA twenty years before (No Margin, No Mission). I was told I could only do so after paying a substantial fee and even then, only if I rejoined as a subscriber. I reluctantly did so, leisurely scanning the contents of the journal for psychiatric material. Some months later, I read a review of an article on emergency room visits and admissions due to the side effects of psychotropic drugs (see Blackwell, 2015). In brief, the author of the review noted that lithium was the most frequent cause of admissions and attributed this to excessive and unwise use of the drug. Evidence for this was absent, as well as any attempt to address or establish the use of well-established prescribing guidelines. I wrote a letter to the Editor suggesting this was incorrect and eventually received a reply stating that a group of sub-editors had decided my letter lacked sufficient “impact”. The journal made no attempt to contact either the original authors of the study or the reviewer who had drawn a faulty conclusion. The letter informed me I could contact them myself but it was uncertain they would reply. I concluded that editorial ethics had deteriorated since the days when I was a resident and wrote anonymous editorials and annotations for the Lancet.</p>
<p>It remains to speculate on the degree to which a changing Zeitgeist in the future may create barriers to success for psychiatrists, in general, and psychopharmacologists or neuroscientists, in particular. In writing the biographies of our pioneers, three attributes appear to assist in negotiating the unexpected but inevitable obstacles to be faced during a career. They are<i> prescience</i> (an ability to anticipate change),<i> flexibility</i> (a capacity for adaptation) and <i>fortitude</i> (a resilient attitude to surmount challenge and frustration). A forthcoming biography to be posted on INHN describes and explores this aspect in more detail (Blackwell &amp; Charalampous, 2015).</p>
<p><b>References:</b></p>
<p>Ban TA (Series Ed.) <i>An Oral History of Neuropsychopharmacology,</i> Brentwood, Tennessee, ACNP, 2011.</p>
<p>Blackwell B. <i>Bits and Pieces of a Psychiatrist’s Life,</i> Xlibris, 2012</p>
<p>Blackwell B. No Margin, No Mission. JAMA, 1994; 271: 1466.</p>
<p>Blackwell B. Risks and relevance to lithium usage: Unpublished letter to the Editor of JAMA on INHN.org in Perspectives; 6.25. 2015</p>
<p>Blackwell B &amp; Charalampous K.&nbsp; Kanellos Charalampous: Confronting the Zeitgeist on INHN.org in Biographies. 12. 24. 2015.</p>
<p>&nbsp;</p>
<p>Barry Blackwell<br />December 17, 2015</p></div><!--TYPO3SEARCH_end--></div>
				</div>
				<div id="ie_clearing">&nbsp;</div>
			</div>
		</div>
		<div id="footer">&copy; INHN 2012-2022 ::: INHN Central Office  · Av. Sagrada Familia Esq Nazaret · Córdoba, Córdoba X5000 · Argentina  ::: email: inhn@inhn.org</div>
	</div>
</div>





<script src="IMAGES/URCHIN.JS" type="text/javascript">
</script>
<script type="text/javascript">
_uacct = "UA-39727086-1";
urchinTracker();
</script>
</body>
</html>